-
EP2440936
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2440936
| EP2440936 - HIGHLY SENSITIVE BIOMARKER PANELS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 11.11.2016 Database last updated on 19.07.2024 | Most recent event Tooltip | 11.11.2016 | Withdrawal of application | published on 14.12.2016 [2016/50] | Applicant(s) | For all designated states Singulex, Inc. 1650 Harbor Bay Parkway Suite 200 Alameda, CA 94502-3012 / US | [2012/16] | Inventor(s) | 01 /
GOIX, Philippe, J. 210 Sunnyside Avenue Piedmont, CA 94611 / US | 02 /
PUSKAS, Robert 752 Sherwick Terrace Manchester, MO 63021 / US | 03 /
TODD, John 1096 Orchard Road Lafayette, CA 94549 / US | 04 /
LIVINGSTON, Richard 468 Florence Avenue Webster Groves, MO 63119 / US | 05 /
HELD, Douglas 1219 Weatherton Place Ballwin, MO 63021 / US | 06 /
LE, Sara 1517 6th Street Berkeley, CA 94710 / US | [2012/16] | Representative(s) | Williams, Richard Andrew Norman, et al HGF Limited 140 London Wall London EC2Y 5DN / GB | [N/P] |
| Former [2012/16] | Leoni, Richard Pietro, et al avidity IP Merlin House Falconry Court Baker's Lane, Epping Essex CM16 5DQ / GB | Application number, filing date | 10786631.1 | 07.06.2010 | WO2010US37613 | Priority number, date | US20090185194P | 08.06.2009 Original published format: US 185194 P | [2012/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010144358 | Date: | 16.12.2010 | Language: | EN | [2010/50] | Type: | A1 Application with search report | No.: | EP2440936 | Date: | 18.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.12.2010 takes the place of the publication of the European patent application. | [2012/16] | Search report(s) | International search report - published on: | US | 16.12.2010 | (Supplementary) European search report - dispatched on: | EP | 12.02.2013 | Classification | IPC: | G01N33/68, G01N33/52 | [2012/16] | CPC: |
G01N33/6893 (EP,US);
G01N33/6869 (US);
G01N2333/32 (US);
G01N2333/47 (US);
G01N2333/4712 (EP,US);
G01N2333/525 (EP,US);
G01N2333/54 (EP,US);
G01N2333/5412 (EP,US);
G01N2333/58 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/16] | Title | German: | HOCHEMPFINDLICHE BIOMARKERTAFELN | [2012/16] | English: | HIGHLY SENSITIVE BIOMARKER PANELS | [2012/16] | French: | GROUPES DE BIOMARQUEURS TRÈS SENSIBLES | [2012/16] | Entry into regional phase | 16.12.2011 | National basic fee paid | 16.12.2011 | Search fee paid | 16.12.2011 | Designation fee(s) paid | 16.12.2011 | Examination fee paid | Examination procedure | 16.12.2011 | Examination requested [2012/16] | 17.12.2013 | Amendment by applicant (claims and/or description) | 27.05.2014 | Despatch of a communication from the examining division (Time limit: M06) | 13.01.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 20.03.2015 | Reply to a communication from the examining division | 04.11.2016 | Application withdrawn by applicant [2016/50] | 09.11.2016 | Cancellation of oral proceeding that was planned for 06.12.2016 | 06.12.2016 | Date of oral proceedings (cancelled) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.05.2014 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 20.03.2015 | Request for further processing filed | 20.03.2015 | Full payment received (date of receipt of payment) Request granted | 01.04.2015 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 17.12.2013 | Request for further processing filed | 17.12.2013 | Full payment received (date of receipt of payment) Request granted | 09.01.2014 | Decision despatched | Fees paid | Renewal fee | 31.03.2012 | Renewal fee patent year 03 | 27.06.2013 | Renewal fee patent year 04 | 30.06.2014 | Renewal fee patent year 05 | 29.06.2015 | Renewal fee patent year 06 | 27.06.2016 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA]WO2008048371 (SINGULEX INC [US], et al) [X] 1-9,11-15 * (p 17, para 0062)(p 15, l 15 and l 32)(p 7, para 0027);; claim 61 * [A] 10; | [XA] - ZEN KAN ET AL, "Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy: comparison between nonobstructive and dilated-phase hypertrophic cardiomyopathy.", INTERNATIONAL HEART JOURNAL MAR 2005, (200503), vol. 46, no. 2, ISSN 1349-2365, pages 231 - 244, XP002691090 [X] 1-9,11-15 * abstract * [A] 10 DOI: http://dx.doi.org/10.1536/ihj.46.231 | [XPA] - PIERRE N FLORIANO ET AL, "Use of Saliva-Based Nano-Biochip Tests for Acute Myocardial Infarction at the Point of Care: A Feasibility Study", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, vol. 55, no. 8, doi:10.1373/CLINCHEM.2008.117713, ISSN 0009-9147, (20090801), pages 1530 - 1538, (20090625), XP008150866 [XP] 1-9,11-15 * abstract * [A] 10 DOI: http://dx.doi.org/10.1373/clinchem.2008.117713 | International search | [X]WO2008048371 (SINGULEX INC [US], et al); | [X] - SABATINE ET AL., "Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.", EUR HEART J, (200901), XP055050708 DOI: http://dx.doi.org/10.1093/eurheartj/ehn504 | [Y] - KOEHNLEIN ET AL., "Increased cardiac troponin T and C-reactive protein levels in end-stage renal disease are associated with obstructive sleep apnea.", CLIN NEPHROL JANUARY, (2009), vol. 71, no. 1, pages 50 - 58, XP009166436 DOI: http://dx.doi.org/10.5414/CNP71050 | [Y] - VAN WISSEN ET AL., "Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy.", ATHEROSCLEROSIS, (200212), vol. 165, no. 2, pages 361 - 366, XP001204988 DOI: http://dx.doi.org/10.1016/S0021-9150(02)00280-0 | [A] - KATUS ET AL., "Higher sensitivity troponin assays: Quo vadis?", EUR HEART J, (200901), vol. 30, no. 2, pages 127 - 128, XP055050704 DOI: http://dx.doi.org/10.1093/eurheartj/ehn555 |